Platelet antibody: review of detection methods

Area of Science:

• Immunology
• Hematology
• Clinical Chemistry

Background:

• Platelet destruction identification drives in vitro platelet antibody assay development.
• Early methods focused on platelet activation, while current assays utilize specific antibodies against immunoglobulin or complement, often labeled.
• Significant variability exists in quantifying platelet-associated IgG across different methods.

Purpose of the Study:

• To review the evolution and current state of in vitro platelet antibody detection methods.
• To highlight the challenges and limitations in current quantitative assays for platelet antibodies.
• To outline the clinical applications and potential of these assays in diagnosing and managing thrombocytopenias.

Main Methods:

• Review of existing literature on in vitro platelet antibody detection.
• Comparison of different quantitative and qualitative assay methodologies.
• Analysis of factors contributing to assay variability and limitations.

Main Results:

• Current methods use labeled secondary antibodies (e.g., 125I, enzyme, fluorescein) for enhanced specificity.
• Discrepancies in results are linked to secondary antibody binding differences and incorrect binding ratio assumptions.
• Assays are valuable for diagnosing neonatal isoimmune thrombocytopenia, posttransfusion purpura, differentiating immune/non-immune thrombocytopenias, identifying drug-induced thrombocytopenia, and cross-matching for refractory patients.

Conclusions:

• While current assays are clinically useful for specific diagnoses and patient stratification, variability in quantitative results persists.
• Further investigation is needed to validate the predictive value of quantitative assays for patient outcomes and treatment responses.
• Refinement of assay methodologies is crucial to overcome limitations and improve diagnostic accuracy in immune-mediated platelet disorders.